Prudential Financial’s Apogee Therapeutics APGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.38M Buy
63,900
+9,600
+18% +$697K 0.01% 895
2025
Q4
$4.1M Buy
54,300
+41,440
+322% +$2.61M ﹤0.01% 1004
2025
Q3
$511K Sell
12,860
-55,985
-81% -$2.14M ﹤0.01% 1945
2025
Q2
$2.99M Buy
68,845
+43,940
+176% +$1.67M ﹤0.01% 1188
2025
Q1
$930K Buy
24,905
+370
+2% +$14.3K ﹤0.01% 1604
2024
Q4
$1.11M Hold
24,535
﹤0.01% 1536
2024
Q3
$1.44M Buy
24,535
+55
+0.2% +$2.63K ﹤0.01% 1694
2024
Q2
$963K Buy
24,480
+17,715
+262% +$860K ﹤0.01% 1852
2024
Q1
$450K Buy
+6,765
New +$295K ﹤0.01% 2210

Other funds holding APGE